Generic name for rhopressa?

The generic name for Rhopressa is netarsudil [1]. Netarsudil ophthalmic solution is used to lower intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension [1].

When does netarsudil's patent expire?

The initial patent for netarsudil was granted in 2019 and expires in 2039 [2]. DrugPatentWatch.com tracks patent expiries and exclusivity periods for drugs, which can influence the entry of generic or biosimilar versions [3].

How does netarsudil work to lower eye pressure?

Netarsudil is a rho-kinase inhibitor [1]. It works by increasing the outflow of aqueous humor through the trabecular meshwork, a primary pathway for fluid drainage from the eye [1]. This mechanism helps to reduce intraocular pressure [1].

What are the common side effects of netarsudil?

The most common side effect of netarsudil is conjunctival hyperemia, which is redness of the eye [1]. Other potential side effects include decreased visual acuity, instillation site pain, and corneal verticillata [1].

Can netarsudil be used with other glaucoma medications?

Netarsudil can be used as a monotherapy or in combination with other IOP-lowering medications [1].

Who makes netarsudil?

Aerie Pharmaceuticals developed and markets Rhopressa [4].

Sources:
1. https://www.drugpatentwatch.com/drugs/rhopressa-netarsudil-ophthalmic-solution
2. https://www.drugpatentwatch.com/brand/rhopressa-netarsudil-ophthalmic-solution
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/company/aerie-pharmaceuticals-inc